328 related articles for article (PubMed ID: 19625647)
1. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells.
Murugaiyan G; Mittal A; Lopez-Diego R; Maier LM; Anderson DE; Weiner HL
J Immunol; 2009 Aug; 183(4):2435-43. PubMed ID: 19625647
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.
Ghannam S; Pène J; Moquet-Torcy G; Jorgensen C; Yssel H
J Immunol; 2010 Jul; 185(1):302-12. PubMed ID: 20511548
[TBL] [Abstract][Full Text] [Related]
3. IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer.
Kryczek I; Wu K; Zhao E; Wei S; Vatan L; Szeliga W; Huang E; Greenson J; Chang A; Roliński J; Radwan P; Fang J; Wang G; Zou W
J Immunol; 2011 Apr; 186(7):4388-95. PubMed ID: 21357259
[TBL] [Abstract][Full Text] [Related]
4. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation.
Jin JO; Han X; Yu Q
J Autoimmun; 2013 Feb; 40():28-44. PubMed ID: 22921334
[TBL] [Abstract][Full Text] [Related]
6. Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells.
Chen X; Howard OM; Oppenheim JJ
J Immunol; 2007 May; 178(10):6123-9. PubMed ID: 17475838
[TBL] [Abstract][Full Text] [Related]
7. Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris.
Veldman C; Höhne A; Dieckmann D; Schuler G; Hertl M
J Immunol; 2004 May; 172(10):6468-75. PubMed ID: 15128839
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta.
Rowan AG; Fletcher JM; Ryan EJ; Moran B; Hegarty JE; O'Farrelly C; Mills KH
J Immunol; 2008 Oct; 181(7):4485-94. PubMed ID: 18802051
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory effects of ex vivo human Th17 cells are suppressed by regulatory T cells.
Crome SQ; Clive B; Wang AY; Kang CY; Chow V; Yu J; Lai A; Ghahary A; Broady R; Levings MK
J Immunol; 2010 Sep; 185(6):3199-208. PubMed ID: 20720207
[TBL] [Abstract][Full Text] [Related]
10. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells.
Awasthi A; Carrier Y; Peron JP; Bettelli E; Kamanaka M; Flavell RA; Kuchroo VK; Oukka M; Weiner HL
Nat Immunol; 2007 Dec; 8(12):1380-9. PubMed ID: 17994022
[TBL] [Abstract][Full Text] [Related]
11. A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production.
Newcomb DC; Zhou W; Moore ML; Goleniewska K; Hershey GK; Kolls JK; Peebles RS
J Immunol; 2009 May; 182(9):5317-21. PubMed ID: 19380778
[TBL] [Abstract][Full Text] [Related]
12. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression.
Xiao S; Jin H; Korn T; Liu SM; Oukka M; Lim B; Kuchroo VK
J Immunol; 2008 Aug; 181(4):2277-84. PubMed ID: 18684916
[TBL] [Abstract][Full Text] [Related]
15. Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis.
Dunne A; Ross PJ; Pospisilova E; Masin J; Meaney A; Sutton CE; Iwakura Y; Tschopp J; Sebo P; Mills KH
J Immunol; 2010 Aug; 185(3):1711-9. PubMed ID: 20610650
[TBL] [Abstract][Full Text] [Related]
16. IL-17 immunity in human type 1 diabetes.
Honkanen J; Nieminen JK; Gao R; Luopajarvi K; Salo HM; Ilonen J; Knip M; Otonkoski T; Vaarala O
J Immunol; 2010 Aug; 185(3):1959-67. PubMed ID: 20592279
[TBL] [Abstract][Full Text] [Related]
17. IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients.
Heo YJ; Joo YB; Oh HJ; Park MK; Heo YM; Cho ML; Kwok SK; Ju JH; Park KS; Cho SG; Park SH; Kim HY; Min JK
Immunol Lett; 2010 Jan; 127(2):150-6. PubMed ID: 19895848
[TBL] [Abstract][Full Text] [Related]
18. Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells.
Jones GW; McLoughlin RM; Hammond VJ; Parker CR; Williams JD; Malhotra R; Scheller J; Williams AS; Rose-John S; Topley N; Jones SA
J Immunol; 2010 Feb; 184(4):2130-9. PubMed ID: 20083667
[TBL] [Abstract][Full Text] [Related]
19. Cytokine production profile of CD4+ T cells from patients with active Churg-Strauss syndrome tends toward Th17.
Saito H; Tsurikisawa N; Tsuburai T; Oshikata C; Akiyama K
Int Arch Allergy Immunol; 2009; 149 Suppl 1():61-5. PubMed ID: 19494507
[TBL] [Abstract][Full Text] [Related]
20. Advances in understanding the anti-inflammatory properties of IL-27.
Stumhofer JS; Hunter CA
Immunol Lett; 2008 May; 117(2):123-30. PubMed ID: 18378322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
